EDSA: Edesa Biotech, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 16.51
Enterprise Value ($M) 15.93
Book Value ($M) 2.26
Book Value / Share 0.33
Price / Book 7.29
NCAV ($M) 0.17
NCAV / Share 0.02
Price / NCAV 96.14

Profitability (mra)
Return on Invested Capital (ROIC) -2.67
Return on Assets (ROA) -0.78
Return on Equity (ROE) -1.05

Liquidity (mrq)
Quick Ratio 1.09
Current Ratio 1.09

Balance Sheet (mrq) ($M)
Current Assets 2.07
Assets 4.16
Liabilities 1.90
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -7.01
Net Income -6.17
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -4.89
Cash from Investing 0.00
Cash from Financing 0.59

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-25 13G Stonepine Capital Management, LLC 9.90
02-18 13D Velan Capital Master Fund LP 9.99
02-18 13G/A Satterfield Thomas A Jr 0.00
02-14 13D/A Nijhawan Pardeep 19.99 136.42

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-12-20 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2024-12-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-14 2,673 11,384 23.48
2025-03-13 621 10,498 5.92
2025-03-12 808 20,104 4.02
2025-03-11 2,704 36,326 7.44
2025-03-10 14,453 74,769 19.33

(click for more detail)

Similar Companies
DTIL – Precision BioSciences, Inc. DWTX – Dogwood Therapeutics, Inc.
DYAI – Dyadic International, Inc. ELDN – Eledon Pharmaceuticals, Inc.
ELTX – Elicio Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io